| Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases H Kumar, IS Kim, SV More, BW Kim, DK Choi Natural product reports 31 (1), 109-139, 2014 | 382 | 2014 |
| Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease SV More, H Kumar, IS Kim, SY Song, DK Choi Mediators of inflammation 2013, 2013 | 301 | 2013 |
| The role of free radicals in the aging brain and Parkinson’s disease: convergence and parallelism H Kumar, HW Lim, SV More, BW Kim, S Koppula, IS Kim, DK Choi International journal of molecular sciences 13 (8), 10478-10504, 2012 | 266 | 2012 |
| Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson’s disease model H Kumar, IS Kim, SV More, BW Kim, YY Bahk, DK Choi Evidence-Based Complementary and Alternative Medicine 2013, 2013 | 158 | 2013 |
| Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection SV More, DK Choi Molecular neurodegeneration 10, 1-26, 2015 | 143 | 2015 |
| α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease BW Kim, S Koppula, H Kumar, JY Park, IW Kim, SV More, IS Kim, SD Han, ... Neuropharmacology 97, 46-57, 2015 | 111 | 2015 |
| Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease P Kumar, RK Kaundal, S More, SS Sharma Behavioural brain research 197 (2), 398-403, 2009 | 111 | 2009 |
| Toxin-induced experimental models of learning and memory impairment SV More, H Kumar, DY Cho, YS Yun, DK Choi International journal of molecular sciences 17 (9), 1447, 2016 | 110 | 2016 |
| The role of bioactive compounds on the promotion of neurite outgrowth SV More, S Koppula, BW Kim, DK Choi Molecules 17 (6), 6728-6753, 2012 | 95 | 2012 |
| Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death H Kumar, S Koppula, IS Kim, S Vasant More, BW Kim, DK Choi CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2012 | 85 | 2012 |
| Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson’s disease S Koppula, H Kumar, SV More, BW Kim, IS Kim, DK Choi International journal of molecular sciences 13 (8), 10608-10629, 2012 | 80 | 2012 |
| Promising therapeutics with natural bioactive compounds for improving learning and memory—a review of randomized trials H Kumar, SV More, SD Han, JY Choi, DK Choi Molecules 17 (9), 10503-10539, 2012 | 75 | 2012 |
| Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson’s Disease M SV. Evidence-Based Complementary and Alternative Medicine 2013, 1-15, 2013 | 63 | 2013 |
| β-Asarone (cis-2, 4, 5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells HW Lim, H Kumar, BW Kim, SV More, IW Kim, JI Park, SY Park, SK Kim, ... Food and chemical toxicology 72, 265-272, 2014 | 48 | 2014 |
| Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson’s disease S Koppula, H Kumar, SV More, HW Lim, SM Hong, DK Choi Molecules 17 (10), 11391-11420, 2012 | 43 | 2012 |
| Traditional Korean East Asian medicines and herbal formulations for cognitive impairment H Kumar, SY Song, SV More, SM Kang, BW Kim, IS Kim, DK Choi Molecules 18 (12), 14670-14693, 2013 | 41 | 2013 |
| Neuroprotective role of atractylenolide-I in an in vitro and in vivo model of Parkinson’s disease S More, DK Choi Nutrients 9 (5), 451, 2017 | 37 | 2017 |
| Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies S Vasant More, H Kumar, IS Kim, S Koppulla, BW Kim, DK Choi CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013 | 36 | 2013 |
| A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways BW Kim, SV More, YS Yun, HM Ko, JH Kwak, H Lee, K Suk, IS Kim, ... Acta Pharmacologica Sinica 37 (3), 334-343, 2016 | 32 | 2016 |
| Recent update on the role of Chinese material medica and formulations in diabetic retinopathy S Vasant More, IS Kim, DK Choi Molecules 22 (1), 76, 2017 | 29 | 2017 |
